Clinical and non-clinical use of MDMA.
Tidsskr Nor Laegeforen June 10, 2026 Tor-Morten Kvam, Ivar W Goksøyr, Lowan H. Stewart et al.
Clinical and non-clinical use of MDMA.
Mark Berthold-Losleben
5 papers in the library · 9 citations · publishing 2025-2026
Papers
MDMA-assisted psychotherapy in major depression: critical considerations for clinical translation: commentary, Kvam et al.
Br J Psychiatry March 6, 2026 Tor-Morten Kvam, Ivar Walderhaug Goksøyr, Justyna Rog et al.
MDMA-assisted psychotherapy in major depression: critical considerations for clinical translation: commentary, Kvam et al.
MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study - CORRIGENDUM.
Br J Psychiatry February 10, 2026 Tor-Morten Kvam, Ivar W Goksøyr, Justyna Rog et al.
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial
Journal of Psychiatric Research November 27, 2025 Tor-Morten Kvam, Ivar W Goksøyr, Joanna Róg et al. 3 citations
BACKGROUND: Major depressive disorder (MDD) is a leading cause of global disability, and current treatments often fail to provide sustained effectiveness. MDMA-assisted therapy (MDMA-AT) is a promising treatment for MDD. However, the long-term effects are not known. OBJECTIVES: To examine the long-term effects of MDMA-AT for MDD. METHODS: Twelve participants with MDD and an ongoing moderate to...
MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study.
The British journal of psychiatry : the journal of mental science July 11, 2025 Tor-Morten Kvam, Ivar W Goksøyr, Justyna Rog et al. 6 citations
3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy (MDMA-AT) has shown promising safety and efficacy in phase 3 studies of post-traumatic stress disorder, but has not been investigated for a primary diagnosis of major depressive disorder (MDD). We aimed to explore the proof of principle and safety as a first study with MDMA-AT for MDD, and to provide preliminary efficacy data. Twelve...